Next Article in Journal
Potential of Bovine Herpesvirus Vectors for Recombinant Vaccines
Previous Article in Journal
Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18–49 Years of Age Enrolled at Center for Indigenous Health Sites
Previous Article in Special Issue
Evaluation of Immunogenicity of Mycobacterium tuberculosis ag85ab DNA Vaccine Delivered by Pulmonary Administration
 
 
Article

Article Versions Notes

Vaccines 2026, 14(1), 5; https://doi.org/10.3390/vaccines14010005 (registering DOI)
Action Date Notes Link
article html file updated 19 December 2025 16:28 CET Original file https://www.mdpi.com/2076-393X/14/1/5/html
article supplementary file uploaded. 19 December 2025 16:24 CET - https://www.mdpi.com/2076-393X/14/1/5#supplementary
article pdf uploaded. 19 December 2025 16:24 CET Version of Record https://www.mdpi.com/2076-393X/14/1/5/pdf
article xml uploaded. 19 December 2025 16:24 CET Update https://www.mdpi.com/2076-393X/14/1/5/xml
article xml file uploaded 19 December 2025 16:24 CET Original file -
Back to TopTop